Aster Capital Management DIFC Ltd Has $2.86 Million Position in HCA Healthcare, Inc. $HCA

Aster Capital Management DIFC Ltd grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 38.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 6,711 shares of the company’s stock after acquiring an additional 1,868 shares during the quarter. HCA Healthcare comprises approximately 1.4% of Aster Capital Management DIFC Ltd’s holdings, making the stock its 5th largest position. Aster Capital Management DIFC Ltd’s holdings in HCA Healthcare were worth $2,860,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Sovran Advisors LLC raised its position in shares of HCA Healthcare by 1.0% during the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after buying an additional 22 shares in the last quarter. Centerpoint Advisors LLC lifted its position in HCA Healthcare by 11.0% in the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after purchasing an additional 22 shares during the period. Cary Street Partners Financial LLC raised its stake in shares of HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after buying an additional 22 shares in the last quarter. Hemington Wealth Management boosted its stake in HCA Healthcare by 11.0% during the third quarter. Hemington Wealth Management now owns 253 shares of the company’s stock valued at $107,000 after buying an additional 25 shares in the last quarter. Finally, Hurley Capital LLC lifted its holdings in HCA Healthcare by 0.5% in the 3rd quarter. Hurley Capital LLC now owns 4,576 shares of the company’s stock valued at $1,950,000 after acquiring an additional 25 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. This represents a 8.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,214 shares of company stock valued at $7,797,595 over the last 90 days. 1.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms recently commented on HCA. KeyCorp set a $503.00 target price on shares of HCA Healthcare in a report on Wednesday, January 28th. Mizuho increased their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday. Truist Financial upped their target price on HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Barclays lifted their price target on HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 28th. Finally, Wells Fargo & Company raised their target price on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a report on Friday, January 30th. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $534.50.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $525.56 on Friday. The stock has a 50-day simple moving average of $492.87 and a 200-day simple moving average of $458.92. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $552.90. The firm has a market cap of $117.53 billion, a price-to-earnings ratio of 18.52, a P/E/G ratio of 1.66 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s payout ratio is presently 10.15%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.